Gilead blockiert Zugang zu lebensrettendem HIV-Medikament
|
Gilead blockiert den Zugang zu Lenacapavir, einem
potenziell lebensrettenden HIV-Medikament, was zu globaler Kritik
führt. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

|
Gilead blockiert den Zugang zu Lenacapavir, einem
potenziell lebensrettenden HIV-Medikament, was zu globaler Kritik
führt. |